233 related articles for article (PubMed ID: 14690663)
1. Cell proliferation and tumour suppressor gene expression in iodine unstained area surrounding oral squamous cell carcinoma.
Yokoo K; Noma H; Inoue T; Hashimoto S; Shimono M
Int J Oral Maxillofac Surg; 2004 Jan; 33(1):75-83. PubMed ID: 14690663
[TBL] [Abstract][Full Text] [Related]
2. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?
Chen YK; Hsue SS; Lin LM
Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192
[TBL] [Abstract][Full Text] [Related]
3. Patterns of p53 and Ki-67 protein expression in epithelial dysplasia from the floor of the mouth.
Kushner J; Bradley G; Jordan RC
J Pathol; 1997 Dec; 183(4):418-23. PubMed ID: 9496258
[TBL] [Abstract][Full Text] [Related]
4. Higher expressions of p53 and proliferating cell nuclear antigen (PCNA) in atrophic oral lichen planus and patients with areca quid chewing.
Lee JJ; Kuo MY; Cheng SJ; Chiang CP; Jeng JH; Chang HH; Kuo YS; Lan WH; Kok SH
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Apr; 99(4):471-8. PubMed ID: 15772596
[TBL] [Abstract][Full Text] [Related]
5. Proliferating cell nuclear antigen (PCNA) and p53 in epithelial dysplasia and squamous cell carcinoma of oral mucosa--a marker for poor tumor differentiation, increasing nuclear atypia and invasiveness?
Lan HA; Zain RB; Saitoh M; Muramatsu Y; Shrestha P; Mori M
Anticancer Res; 1996; 16(5B):3059-65. PubMed ID: 8920767
[TBL] [Abstract][Full Text] [Related]
6. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
[TBL] [Abstract][Full Text] [Related]
7. Expression of p63 protein and mRNA in oral epithelial dysplasia.
Chen YK; Hsue SS; Lin LM
J Oral Pathol Med; 2005 Apr; 34(4):232-9. PubMed ID: 15752259
[TBL] [Abstract][Full Text] [Related]
8. [A study on expressions of P53 protein and proliferating cell nuclear antigen in malignant eyelid tumors].
Niu Y; Wang H; Ji J; Lin H; Zhang A
Zhonghua Yan Ke Za Zhi; 1999 Jan; 35(1):36-9, 5. PubMed ID: 11835772
[TBL] [Abstract][Full Text] [Related]
9. [P53 expression and clinical significance in oral squamous cell carcinoma].
Long Y; Ling D; Yue W
Hua Xi Kou Qiang Yi Xue Za Zhi; 1997 May; 15(2):115-6, 122. PubMed ID: 11480024
[TBL] [Abstract][Full Text] [Related]
10. Markers for dysplasia of the upper aerodigestive tract. Suprabasal expression of PCNA, p53, and CK19 in alcohol-fixed, embedded tissue.
Coltrera MD; Zarbo RJ; Sakr WA; Gown AM
Am J Pathol; 1992 Oct; 141(4):817-25. PubMed ID: 1384338
[TBL] [Abstract][Full Text] [Related]
11. Proliferating cell nuclear antigen (PCNA) as a marker of dysplasia in oral mucosa.
Martínez-Lara I; González-Moles MA; Ruiz-Avila I; Bravo M; Ramos MC; Fernández-Martínez JA
Acta Stomatol Belg; 1996 Mar; 93(1):29-32. PubMed ID: 8986050
[TBL] [Abstract][Full Text] [Related]
12. Early progression stage of malignancy of uterine cervical dysplasia as revealed by immunohistochemical demonstration of increased DNA-instability.
Khaled A; Imamura Y; Noriki S; Fukuda M
Eur J Histochem; 2000; 44(2):143-56. PubMed ID: 10968362
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical study of p53 and angiogenesis in benign and preneoplastic oral lesions and oral squamous cell carcinoma.
Abbas NF; Labib El-Sharkawy S; Abbas EA; Abdel Monem El-Shaer M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):385-90. PubMed ID: 17321451
[TBL] [Abstract][Full Text] [Related]
14. The expression of tumorigenesis markers in oral papilloma.
Reszeć J; Sulkowska M; Famulski W; Guzińska-Ustymowicz K; Sulkowski S
Pol J Pathol; 2002; 53(4):195-200. PubMed ID: 12597336
[TBL] [Abstract][Full Text] [Related]
15. Clinical impact of iodine staining for diagnosis of carcinoma in situ in the floor of mouth, and decision of adequate surgical margin.
Watanabe A; Taniguchi M; Tsujie H; Hosokawa M; Fujita M; Sasaki S
Auris Nasus Larynx; 2012 Apr; 39(2):193-7. PubMed ID: 21885222
[TBL] [Abstract][Full Text] [Related]
16. Histopathological evaluation including cytokeratin 13 and Ki-67 in the border between Lugol-stained and -unstained areas.
Ohta K; Ogawa I; Ono S; Taki M; Mizuta K; Miyauchi M; Takechi M; Shigeishi H; Takata T; Kamata N
Oncol Rep; 2010 Jul; 24(1):9-14. PubMed ID: 20514438
[TBL] [Abstract][Full Text] [Related]
17. p53 immunoexpression in non-malignant oral mucosa adjacent to oral squamous cell carcinoma: potential consequences for clinical management.
Cruz IB; Meijer CJ; Snijders PJ; Snow GB; Walboomers JM; van Der Waal I
J Pathol; 2000 Jun; 191(2):132-7. PubMed ID: 10861571
[TBL] [Abstract][Full Text] [Related]
18. [Changes of simple epithelial cytokeratin during oral carcinogenesis].
Nie M; Li B; Zeng G; He Z; Chen Q; Zhou M; Luo G; Zeng X
Hua Xi Kou Qiang Yi Xue Za Zhi; 1999 Aug; 17(3):208-9, 220. PubMed ID: 12539284
[TBL] [Abstract][Full Text] [Related]
19. p53 immunoexpression: an aid to conventional methods in the screening of precursor lesions of squamous esophageal cancer in patients at high-risk?
Fagundes RB; Melo CR; Pütten AC; Moreira LF; de Barros SG
Cancer Detect Prev; 2005; 29(3):227-32. PubMed ID: 15936591
[TBL] [Abstract][Full Text] [Related]
20. p53 expression in oral cancer: observations of a South Indian study.
Pillay M; Vasudevan DM; Rao CP; Vidya M
J Exp Clin Cancer Res; 2003 Sep; 22(3):447-51. PubMed ID: 14582705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
